Navigation Links
Perforomist in Medical News

Concomitant use of Perforomist & tiotropium -- significant improvements -- COPD

Napa, CA (May 20, 2008) Data presented today at the International Conference of the American Thoracic Society (ATS) demonstrate that concomitant therapy with Perforomist Inhalation Solution (formoterol fumarate inhalation solution; FFIS), delivered by nebulization, and Spiriva (tiotropium; TIO) i...

Perforomist Inhalation Solution data to be presented today at American Thoracic Society conference

...ata from two presentations highlighting the use of perforomist (formoterol fumarate) Inhalation Solution in moder...cic Society in San Diego. In one analysis, use of perforomist Inhalation Solution, when added to maintenance tio...tient satisfaction increased in those treated with perforomist Inhalation Solution twice daily compared with ipra...

Perforomist(R) Inhalation Solution Data in Patients With Moderate to Severe COPD to Be Presented at the International Conference of the American Thoracic Society

...cic Society in San Diego. In one analysis, use of perforomist Inhalation Solution, when added to maintenance tio...tient satisfaction increased in those treated with perforomist Inhalation Solution twice daily compared with ipra... metered-dose inhaler (MDI) four times daily. perforomist Inhalation Solution was approved in 2007 by the U....

Perforomist Inhalation Solution data to be presented at American Thoracic Society conference

...ata from two presentations highlighting the use of perforomist (formoterol fumarate) Inhalation Solution will be ...9, 2009 in San Diego. In one analysis, use of perforomist Inhalation Solution, when added to maintenance tio...tient satisfaction increased in those treated with perforomist Inhalation Solution twice daily compared with ipra...

Dey, L.P. Highlights Perforomist(R) Inhalation Solution Data to Be Presented at the International Conference of the American Thoracic Society

... 2009 in San Diego. In one analysis, use of perforomist Inhalation Solution, when added to maintenance tio...tient satisfaction increased in those treated with perforomist Inhalation Solution twice daily compared with ipra...vering medicine directly into the lungs. With perforomist Inhalation Solution, nebulization may become a mor...

Concomitant treatment with nebulized formoterol fumarate & tio-significant improvements -- COPD

...fficacy and safety of the concomitant treatment of perforomist nebulized formoterol fumarate (a long-acting β...thor and principal investigator of the study. When perforomist Solutions rapid onset of action is combined with t...ta Results from the Phase III pivotal trial of perforomist (formoterol fumarate) Inhalation Solution, the fir...

Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD

...ilable version of nebulized formoterol fumarate is perforomist Inhalation Solution, which is indicated for long-t...ion and has twenty years of worldwide experience. perforomist Inhalation Solution is the first and only FDA-appr...ion over use of tiotropium alone. For physicians, perforomist Inhalation Solution and commonly prescribed long-a...
Perforomist in Medical Technology

PARI LC Plus and PRONEB Ultra Used in Two Perforomist Studies on Improving COPD Therapies

MIDLOTHIAN, Va., June 30 /PRNewswire/ -- In two recent COPD studies sponsored by DEY LP, PARI's LC Plus nebulizer and PRONEB compressors (Ultra and Ultra II) were used to show that nebulized formoterol fumarate (Perforomist, DEY LP, Mylan Inc.) improves pulmonary function. "We are pleased th...

Clinical Trial Data for Perforomist Inhalation Solution to be Presented at ATS on May 20, 2007

-- Data from Phase III pivotal trial demonstrate safety and efficacy of first FDA-approved nebulized formoterol fumarate for patients with moderate to severe COPD -- NAPA, Calif., May 16, 2007 /PRNewswire/ -- Dey, L.P. announced that two clinical data presentations will be given at the Internation...

Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

-- New product recently approved by FDA for long-term maintenance treatment of COPD bronchoconstriction; data demonstrate first nebulized formoterol fumarate provides improved lung function comparable to dry powder formoterol, enhanced patient quality of life, and positive safety profile -- NAPA, ...

Clinical Trial Data for Perforomist (Formoterol Fumarate) Inhalation Solution Presented at International ATS Conference

-- New product recently approved by FDA for long-term maintenance treatment of COPD bronchoconstriction; data demonstrate first nebulized formoterol fumarate provides improved lung function comparable to dry powder formoterol, enhanced patient quality of life, and positive safety profile -- NAPA...

Concomitant Use of Nebulized Formoterol Fumarate and Tiotropium Provides Significant Improvement in Dyspnea, COPD Symptoms and Rescue Medication Use over Tiotropium Alone

... careful investigation into the clinical benefits of concomitant therapy of perforomist and tiotropium. At DEY, we are committed to developing effective new treatments for serious and complex diseases, and with perforomist are proud to provide physicians and patients a twice-daily COPD maintenance...

Clinical Trial Data on the Safety and Efficacy of Concomitant Formoterol Fumarate/ Tiotropium Treatment for COPD

...neb.com, http://www.curosurfusa.com, http://www.cyanokit.com, http://www.duoneb.com, http://www.epipen.com and http://www.perforomist.com . perforomist is a trademark of Dey, L.P. About Mylan Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company...

Data from Three Clinical Trials for Perforomist(TM) Inhalation Solution to be Presented at CHEST 2007 on October 24, 2007

...www.duoneb.com, http://www.epipen.com and http://www.perforomist.com . perforomist is a trademark of Dey, L.P. About Mylan Mylan Inc. is one of the world's ...ents that constitute "forward-looking statements," including with regard to perforomist and research results. These statements are made pursuant to the safe harbor...
Perforomist in Biological Technology

PARI Respiratory's LC PLUS & PRONEB Ultra Deliver Dey, L.P.'s New COPD Therapy; Perforomist Launched Yesterday

MIDLOTHIAN, Va., Oct. 9 /PRNewswire/ -- PARI Respiratory Equipment's breath-enhanced nebulizer, the PARI LC PLUS, and PRONEB Ultra compressor deliver Dey, L.P.'s new COPD medication, Perforomist Inhalation Solution, that launched nationwide yesterday. Dey, L.P. is a subsidiary of Mylan Inc. (N...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

...llion, compared to $183.0 million for the six months ended June 30, 2008. EpiPen was the primary driver of the increase in revenues. Higher sales of perforomist were offset by lower sales of DuoNeb(R), which continues to experience the unfavorable impact of generic competition, which first entered the market i...

Mylan Inc. Subsidiary, Dey, L.P., Announces that Perforomist(TM) (Formoterol Fumarate) Inhalation Solution is Now Available for Maintenance Treatment of COPD

...neb.com, http://www.curosurfusa.com, http://www.cyanokit.com, http://www.duoneb.com, http://www.epipen.com and http://www.perforomist.com . perforomist is a trademark of Dey, L.P. About Mylan Mylan Inc. is one of the world's leading quality generic and specialty pharmaceutical companies. The Company...
Other Tags
(Date:5/4/2015)... “ LiveSchool ” was featured on ... a look at the latest and coolest applications on ... the host of AppWatch and technology expert, conducted the ... allows teachers to reward students with good behavior. , ... in the classroom. And the good people at ...
(Date:5/4/2015)... 2015 The opportunity for children to dream ... the motivating forces behind The Fairy Godmother Next Door, a ... Amy L. Stark. , The inspiration for the enchanting story ... comes from Stark’s desire to be a fairy godmother. , ... godmother to my neighbors’ children since they were born. We ...
(Date:5/4/2015)... 2015 The U.S. healthcare worker shortage ... the ranks of senior citizens (1) and 27 million ... over-burdened healthcare system. Additionally, as older healthcare employees retire, ... Per the U.S. Census Bureau, the number of American ... by 2050 while those 25 to 54 will likely ...
(Date:5/4/2015)... and Seattle, WA (PRWEB) May 04, 2015 ... formation of a collaboration to facilitate development of NM108, ... ophthalmic disorders that lead to blindness, including Diabetic Retinopathy. ... MiDROPS™ formulation platform developed by EyeCRO, which can deliver ... via a topical eyedrop. , Under the terms ...
(Date:5/4/2015)... New findings released today from a ... show that people diagnosed with a brain tumor needed ... clinical trials, at the time of diagnosis, and had ... about their course of treatment. The release of these ... brain tumor volunteer network, the ABTA CommYOUnity™, dedicated to ...
Breaking Medicine News(10 mins):Health News:An Application for Teachers to Reward Students with Good Behavior Was Featured on NewsWatch Television 2Health News:Introducing New Children’s Book The Fairy Godmother Next Door 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 2Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 3Health News:U.S. Healthcare Worker Shortage Escalating: Sterling Warns Medical Practitioners to Rapidly Reverse Low Employee Retention 4Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 2Health News:EyeCRO and NeuMedics Announce Collaboration to Utilize MiDROPS™ Technology for the Development of NM108 3Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 2Health News:American Brain Tumor Association Poll Underscores Need for Greater Awareness and Education at Time of Diagnosis 3
(Date:4/2/2015)... 2, 2015 In the ... far outperforms the strongest competitors, showing outstanding performance ... the system is capable of a throughput of ... up to be ten times faster than most ... performance.      (Photo: http://photos.prnewswire.com/prnh/20150402/738673-a ...
(Date:4/2/2015)... 2015 According to preliminary estimates ... somewhat higher than 125 MSEK. This exceeds the guidance ... that revenues for Q1 2015 would be in line ... Q4 2014. The operating result for the first quarter ... interim report will as previously communicated be published on ...
(Date:4/1/2015)... , Apr. 1, 2015  NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces ... smart wallets is underway to early access pre-order customers. ... includes usage at retail outlets including Walmart, Target, AT&T, ... report Wocket was accepted at all outlets and very ...
Breaking Biology News(10 mins):DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 2DERMALOG AFIS Emerges as Performance Winner in NIST Benchmark Test 3Fingerprint Cards Revises Revenues for Q1 2015 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 2NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 3NXT-ID Reports Second Shipment of Wocket Smart Wallets Underway to Early Access Pre-order Customers and Provides User Feedback 4
Other Contents